Credit Suisse’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $5.16M | Buy |
|
|||||
|
2022
Q4 | $949K | Buy |
|
|||||
|
2022
Q3 | $160K | Buy |
|
|||||
|
2022
Q2 | $140K | Sell |
|
|||||
|
2022
Q1 | $271K | Sell |
|
|||||
|
2021
Q4 | $214K | Buy |
|
|||||
|
2021
Q3 | $227K | Buy |
|
|||||
|
2021
Q2 | $262K | Sell |
|
|||||
|
2021
Q1 | $375K | Sell |
|
|||||
|
2020
Q4 | $807K | Buy |
|
|||||
|
2020
Q3 | $311K | Buy |
|
|||||
|
2020
Q2 | $335K | Buy |
|
|||||
|
2020
Q1 | $200K | Sell |
|
|||||
|
2019
Q4 | $1.84M | Buy |
|